Dr. Hinrichs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Rockville Pike
Rm 3-3888
Bethesda, MD 20892Phone+1 301-435-3027
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2014
- George Washington UniversityResidency, Internal Medicine, 2009 - 2010
- University of Missouri Kansas City School of MedicineClass of 1996
Certifications & Licensure
- NJ State Medical License 2020 - 2025
- DC State Medical License 2009 - 2020
- VA State Medical License 2009 - 2010
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols Start of enrollment: 2016 Apr 11
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers Start of enrollment: 2017 Jan 27
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers Start of enrollment: 2024 Jun 12
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer.Zhijian Duan, Dan Li, Nan Li, Shaoli Lin, Hua Ren
Molecular Therapy. Oncology. 2024-12-19 - 1 citationsCAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review.Jennifer N Brudno, Marcela V Maus, Christian S Hinrichs
JAMA. 2024-12-10 - Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants.Ling Zhang, Scott M Norberg, Farrah Karimipour, John S Davies, Alex Kuznetsov
Journal for Immunotherapy of Cancer. 2024-11-18
Press Mentions
- CAR-T Cells and Beyond: Breakthroughs and Challenges AheadDecember 16th, 2024
- The Next Generation of Treatments for Advanced Cervical CancerAugust 27th, 2021
- Anuzis: U.S. Drug Industry Saving Lives – if Congress Doesn’t Squelch ItJune 4th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: